Bids Are Invited For Price Registration, For A Period Of 1 Year, Which Can Be Extended For The Same Period, As Long As The Advantageous Price Is Proven, For Future And Eventual Acquisition Of Medicines

(L1) 6501.2582-Acebrophylline, 5 Mg/Ml (Pediatric), Syrup, Bottle, 120 Ml, Dosing Cup/Syringe, Route Of Administration: Oral, Units. Size: Unit, (L2) 6501.217-Acetylcysteine, 100 Mg/Ml (10%), Injectable Solution, Ampoule, 3 Ml, Route Of Administration: Intravenous/Inhalation, (L3) 6501.228-Folic Acid, 5 Mg, Tablet, Blister, (L4) 6501.251-Allopurinol, 300 Mg, (L5) 6501.1217-Ampicillin Sodium, 1 G, Powder For Injection Solution, Ampoule Vial, Route Of Administration: Intramuscular/Intravenous, 09/18/2023, (L6) 6501.322 -Ceftriaxone Disodium, Route Of Administration: Intravenous, (L7) 6501.512-Clonidine, Hydrochloride, 0.1 Mg, (L8) 6501.747-Enalapril, Maleate, 10 Mg, (L9) 6501.754-Epinephrine, Hemitartrate (Adrenaline), 1 Mg /Ml, 1 Ml, Route Of Administration: Subcutaneous/Intramuscular/Intravenous, (L10) 6501.1351-Sodium Heparin, 5,000 Iu/Ml, 5 Ml, (L11) 6501.4797-Oxytocin, 5 Iu/Ml, (L12) 6502.1034-Carbonate Lithium, Ordinance 344/98: C1, (L13) 6502.1090-Chlorpromazine, 40 Mg/Ml, Drops Solution, Drip Bottle, 20 Ml, (L14) 6502.1089-Chlorpromazine, 5 Mg/Ml, Route Of Administration: Intramuscular, ( L15) 6502.1124-Fentanyl, Citrate, 05 Mg/Ml, 2 Ml, Route Of Administration: Intramuscular/Intravenous/Epidural/Intrathecal, Ordinance 344/98: A1, (L16) 6502.1126-Flumazenil, (L17) 6502.1140-Haloperidol, ( L18) 6502.1169-Naloxone, 4 Mg/Ml, (L19) 6501.75351-Caffeine, 20 Mg/Ml, Solution, Route Of Administration: Intravenous/Oral, (L20) 6501.3709-Levobupivacaine, Hydrochloride + Epinephrine, Hemitartrate, 5 Mg/Ml (0.5%) + 9.1 Mcg/Ml, Route Of Administration: Other Parenteral Routes, (L21) 6501.1755-Hidralazine